Perspectives

4/11/2025 6:10:03 PM

Update on Status of Rescheduling Cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act

By Daniel McGee

There have been years of debate as to whether or not cannabis should be classified under Schedule I (high potential for abuse, no...

4/11/2025 6:07:22 PM

By Daniel McGee

The hemp-beverage market, fueled by shifts in consumer behavior and government allowances, is drawing traditional retailers and...

4/8/2025 7:52:26 PM

By Daniel McGee

As reported last week by Reuters, the sweeping tariffs imposed by President Donald Trump on Wednesday, April 2 are slated to increase...

4/7/2025 6:51:45 PM

By Daniel McGee

Last year, the Florida Legislature passed a bill to regulate the sale and production of currently legal hemp-derived cannabinoid products...

4/7/2025 2:28:06 PM

By Daniel McGee

On April 2, Bidi Vapor LLC petitioned the Eleventh Circuit U.S. Court of Appeals to overturn a decision by the U.S. Food and Drug...

4/3/2025 7:55:12 PM

By Daniel McGee

As discussed in our prior post, Texas, like many state legislatures, is currently considering heightened regulation of the hemp derived...

3/26/2025 6:07:00 PM

By Daniel McGee

SB 265 On March 11, 2025, the North Carolina Senate introduced the Protecting Our Communities Act (SB 265), which attempts to establish...

3/25/2025 8:45:49 PM

By Daniel McGee

On Wednesday, March 19, the Texas Senate passed Senate Bill 3 (SB 3), a state ban on all forms of THC in an attempt to crack down on the...

10/1/2024 9:00:24 PM

By Will Garvin

Senator Wyden introduced legislation in an effort to create a new regulatory class of products that would consist of hemp-derived...